ABBOTT PARK, Ill., July 11, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new ...
How important are diagnostic tests in clinical decision making? Diagnostic tests are critical as up to 60 to 70% of critical clinical decisions are influenced by diagnostic test results. It's of huge ...
Abbott ABT has hit the headlines following the announcement of the receipt of CE Mark and commercial launch of Alinity h-series integrated system for hematology testing. Per management, the Alinity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results